Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40316
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMULLENS, Wilfried-
dc.contributor.authorSchulze, Paul Christian-
dc.contributor.authorWestphal, Julian-
dc.contributor.authorBogoviku, Juergen-
dc.contributor.authorBauersachs, Johann-
dc.date.accessioned2023-06-06T07:15:15Z-
dc.date.available2023-06-06T07:15:15Z-
dc.date.issued2023-
dc.date.submitted2023-06-02T14:19:06Z-
dc.identifier.citationEUROPEAN HEART JOURNAL, 44 , p. 2159-2169-
dc.identifier.urihttp://hdl.handle.net/1942/40316-
dc.description.sponsorshipJo.B. was supported by the Deutsche Forschungsgemeinschaft (KFO 311).-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.rightsThe Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com-
dc.subject.otherAcute heart failure-
dc.subject.otherDiuretic therapy-
dc.subject.otherAcetazolamide-
dc.subject.otherSGLT2 inhibitors-
dc.titleGreat debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice-
dc.typeJournal Contribution-
dc.identifier.epage2169-
dc.identifier.spage2159-
dc.identifier.volume44-
local.bibliographicCitation.jcatA2-
dc.description.notesBauersachs, J (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.-
dc.description.notesbauersachs.johann@mh-hannover.de-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
dc.identifier.doi10.1093/eurheartj/ehad266-
dc.identifier.pmid37207453-
dc.identifier.isi000992618000001-
local.provider.typewosris-
local.description.affiliation[Mullens, Wilfried] Ziekenhuis Oost Limburg, Genk, Belgium.-
local.description.affiliation[Mullens, Wilfried] Hasselt Univ, Diepenbeek Hasselt, Belgium.-
local.description.affiliation[Schulze, Paul Christian; Westphal, Julian; Bogoviku, Juergen] Univ Hosp Jena, Dept Internal Med Cardiol Angiol & Intens Med Care, Jena, Germany.-
local.description.affiliation[Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.fullcitationMULLENS, Wilfried; Schulze, Paul Christian; Westphal, Julian; Bogoviku, Juergen & Bauersachs, Johann (2023) Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice. In: EUROPEAN HEART JOURNAL, 44 , p. 2159-2169.-
item.contributorMULLENS, Wilfried-
item.contributorSchulze, Paul Christian-
item.contributorWestphal, Julian-
item.contributorBogoviku, Juergen-
item.contributorBauersachs, Johann-
crisitem.journal.issn0195-668X-
crisitem.journal.eissn1522-9645-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Great debate_ in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice.pdfPublished version1.08 MBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

3
checked on Apr 30, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.